Severity Of Vascular Disaggregation Effects On Erythrocytes In Patients With Arterial Hypertension With Abdominal Obesity And Dyslipidemia.

被引:0
作者
Medvedev, I. N. [1 ]
机构
[1] Russian State Social Univ, St V Pika 4, Moscow 129226, Russia
来源
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES | 2018年 / 9卷 / 03期
关键词
arterial hypertension; abdominal obesity; dyslipidemia; vascular wall; aggregation; erythrocytes;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The high incidence of thrombosis in patients with arterial hypertension with abdominal obesity and dyslipidemia is caused by the development of pronounced vasopathy in them. Given the high prevalence in the world of a combination of arterial hypertension with abdominal obesity and dyslipidemia, it was important to assess the vascular disaggregation effects on erythrocytes in this category of patients. The aim of the work is to evaluate the disaggregation effects of blood vessels on erythrocytes in patients with arterial hypertension with abdominal obesity and dyslipidemia. 47 patients with arterial hypertension of 1-2 degrees with abdominal obesity and dyslipidemia of the second adulthood were examined. Control is represented by 26 healthy volunteers of the second adult age. The study was performed using biochemical, hematological and statistical methods of investigation. Patients under observation showed an increase in cholesterol in erythrocyte membranes, a decrease in phospholipids in them, and an increase in lipid peroxidation. In patients, spontaneous aggregation of erythrocytes was found to increase. At the same time, they showed a decrease in vascular disaggregation control over red blood cells. We can assume that the weakening of disaggregating vascular effects on erythrocytes is a consequence of metabolic abnormalities that arisen in arterial hypertension with abdominal obesity and dyslipidemia, severe vasospasm and excess lipid peroxidation. The existing vasopathy in these patients increases their risk of thrombosis, which can lead to disability or death.
引用
收藏
页码:1161 / 1165
页数:5
相关论文
共 35 条
  • [1] Anatolyevich VY, 2017, BALI MED J, V6, P216, DOI 10.15562/bmj.v6i1.483
  • [2] [Anonymous], 2012, CARDIOVASCULAR THERA, V4, P31
  • [3] Bikbulatova AA, 2018, RES J PHARM BIOL CHE, V9, P677
  • [4] Bikbulatova AA, 2017, Psikhol Nauk Obrazov, V22, P26, DOI 10.17759/pse.2017220105
  • [5] Bikbulatova AA, 2017, Psikhol Nauk Obrazov, V22, P81, DOI 10.17759/pse.2017220110
  • [6] Resveratrol Improves Vascular Function in Patients With Hypertension and Dyslipidemia by Modulating NO Metabolism
    Carrizzo, Albino
    Puca, Annibale
    Damato, Antonio
    Marino, Marina
    Franco, Elio
    Pompeo, Franco
    Traficante, Anna
    Civitillo, Fabio
    Santini, Luigi
    Trimarco, Valentina
    Vecchione, Carmine
    [J]. HYPERTENSION, 2013, 62 (02) : 359 - 366
  • [7] Cuspidi Cesare, 2008, Expert Rev Cardiovasc Ther, V6, P731, DOI 10.1586/14779072.6.5.731
  • [8] Diagnosis and treatment of hypertension, 2010, NATL CLIN RECOMMENDA, P463
  • [9] Cell aging in relation to stress arousal and cardiovascular disease risk factors
    Epel, ES
    Lin, J
    Wilhelm, FH
    Wolkowitz, OM
    Cawthon, R
    Adler, NE
    Dolbier, C
    Mendes, WB
    Blackburn, EH
    [J]. PSYCHONEUROENDOCRINOLOGY, 2006, 31 (03) : 277 - 287
  • [10] Classical and Novel Biomarkers for Cardiovascular Risk Prediction in the United States
    Folsom, Aaron R.
    [J]. JOURNAL OF EPIDEMIOLOGY, 2013, 23 (03) : 158 - 162